Stem Point Capital LP Silence Therapeutics PLC Call Options Transaction History
Stem Point Capital LP
- $340 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SLN
# of Institutions
69Shares Held
26.6MCall Options Held
0Put Options Held
0-
Tcg Crossover Management, LLC Palo Alto, CA3.3MShares$57.7 Million9.38% of portfolio
-
Artal Group S.A. Luxembourg, N42.78MShares$48.7 Million3.35% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY2.41MShares$42.2 Million3.46% of portfolio
-
Redmile Group, LLC San Francisco, CA2.01MShares$35.3 Million2.5% of portfolio
-
Logos Global Management LP San Francisco, CA1.48MShares$25.9 Million2.63% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $629M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...